Prostatype Genomics AB VS Pharmaceuticals & Biotechnology 
1D
-3.83%
-0.26%
1W
-44.17%
-0.88%
1M
-30.93%
3.75%
YTD
-11.92%
14.36%
1Y
-65.51%
27.26%
3Y
-99.57%
49.63%
5Y
-99.96%
37.29%
10Y
%
132.69%
- Stock Absolute Returns
- OMX Stockholm 30Absolute Returns
Price + DividendTotal Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-62.37%
0%
-62.37%
6 Months
-81.07%
0%
-81.07%
1 Year
-65.51%
0%
-65.51%
2 Years
-95.85%
0%
-95.85%
3 Years
-99.57%
0%
-99.57%
4 Years
-99.83%
0%
-99.83%
5 Years
-99.96%
0%
-99.96%
Prostatype Genomics AB for the last several years.
Risk Adjusted Returns v/s OMX Stockholm 30Risk Adjusted Returns v/s
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
